Sitagliptin, A Selective Dpp4 Inhibitor, Is Well Tolerated In Patients With Type 2 Diabetes: Pooled Analysis Of 5141 Patients In Clinical Trials For Up To 2 YearsPeter P. Stein,Debora Williams-Herman,Hootan Khatami,Gary Meininger,Elizabeth Round, Danielle Sheng, Matilde Sanchez,Jared Lunceford,Keith D. Kaufman,John M. AmatrudaDIABETES(2007)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要